Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Anthrocell Logo
Anthrocell CB Rank
537322
Heat Score
63
Anthrocell is an Australian biotechnology company that produces and manufactures monoclonal antibody products.
Founded
obfuscation
Private Sydney, New South Wales, Australia11-50 anthrocell.com
Biotechnology
Manufacturing
Pharmaceutical
Overview

Anthrocell
Heat Score
63

Growth Score
pts
in past quarter
Heat Score 63
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Anthrocell

CB Rank
537322
Anthrocell is an Australian biotechnology company that produces and manufactures monoclonal antibody products.
Founded
obfuscation
Private Sydney, New South Wales, Australia11-50 anthrocell.com
Biotechnology
Manufacturing
Pharmaceutical

Key People

Details

Legal Name Anthrocell Pty Ltd
Operating Status Active
Company Type For Profit
Founders  Galina Kaseko
Phone Number +61 2 9209 4116
Contact Email info@anthrocell.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Anthrocell Expression System (ACX™)
A human cell-based platform producing fully human recombinant proteins with human-like glycosylation and post-translational modifications for biopharmaceutical drug development.
Anthrocell Therapeutics (ACT) Monoclonal Antibody Products
A pipeline of monoclonal antibody products targeting breast cancer, currently in pre-clinical in vivo development stages.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 1

Employee Profiles

News
Technology
View Tech Report

Active Website Tech Count

18Anthrocell is actively using 18 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

2Anthrocell has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Anthrocell's headquarters? Anthrocell is located in Sydney, New South Wales, Australia.Who are Anthrocell's competitors? Alternatives and possible competitors to Anthrocell may include Eli Lilly, Amgen, and  Regeneron.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|